Genomics

RSS

Wales participates in the 100,000 Genomes Project

Wales participates in the 100,000 Genomes Project

Wales has joined the 100,000 Genomes Project, the Welsh Government announced today. The project, now a UK-wide initiative, seeks to transform patient care, encourage genomic discovery and drive a thriving genomics sector.

From Genomics England 20 Mar 2018

Verge joins Genomics England’s Discovery Forum industry partnership

Verge joins Genomics England’s Discovery Forum industry partnership

Genomics England and Verge Genomics, a leading artificial intelligence therapeutics company, announced today that Verge will join Genomics England’s Discovery Forum industry partnership. The partnership aims to translate groundbreaking research into innovative treatments, and ultimately patient benefit, as rapidly as possible.

From Genomics England 20 Mar 2018

Genomics England announces new partnership to improve efficiency of next-generation sequencing analysis

Genomics England announces new partnership to improve efficiency of next-generation sequencing analysis

Today (8 January 2018) at the annual J.P. Morgan Healthcare Conference, Edico Genome and Genomics England announced a new partnership to strengthen the accuracy and consistency of next-generation sequencing data analysis in Genomics England’s Rare Disease Pilot.

From Genomics England 20 Mar 2018

Alex’s experiences of living with rare genetic disease

Alex’s experiences of living with rare genetic disease

In this video, meet participant Alexander Masterson and his mum, Kirsty, who speak about what getting a diagnosis from the 100,000 Genomes Project means to them.

From Genomics England 20 Mar 2018

Royal College of Pathologists‘ bulletin provides summary of Tissue Handling Workshop

Royal College of Pathologists‘ bulletin provides summary of Tissue Handling Workshop

A recent article in the Royal College of Pathologists‘ bulletin provides a summary of our recent Tissue Handling Workshop.

From Genomics England 20 Mar 2018

‘Fast track’ project shows promising results in cancer whole genome analyses

‘Fast track’ project shows promising results in cancer whole genome analyses

One key aim of the 100,000 Genomes Project is to improve cancer care for NHS patients. Whole genome sequencing in cancer can enable clinicians to choose better treatments and improve outcomes for patients through personalized medicine.

From Genomics England 20 Mar 2018

Scotland study aims to offer precise diagnoses for people with rare genetic diseases

Scotland study aims to offer precise diagnoses for people with rare genetic diseases

People in Scotland with rare genetic diseases are set to benefit from a DNA study that seeks to improve their diagnoses and treatments.

From Genomics England 20 Mar 2018

Whole Genome Sequencing used as diagnostic solution for TB

Whole Genome Sequencing used as diagnostic solution for TB

Public Health England has announced that Whole Genome Sequencing (WGS) is now being used to identify different strains of tuberculosis (TB).

From Genomics England 20 Mar 2018

Discovery aids understanding of amyotrophic lateral sclerosis

Discovery aids understanding of amyotrophic lateral sclerosis

Researchers have discovered a basic molecular mechanism that sheds light on the disease process underlying amyotrophic lateral sclerosis (ALS).

19 Mar 2018

Genetic variant discovery could improve safety, effectiveness of drugs for asthma and COPD

Genetic variant discovery could improve safety, effectiveness of drugs for asthma and COPD

Research from the University of Liverpool, published today in Lancet Respiratory Medicine, identifies a genetic variant that could improve the safety and effectiveness of corticosteroids, drugs that are used to treat a range of common and rare conditions including asthma, and chronic obstructive pulmonary disease (COPD).

16 Mar 2018

Researchers develop way to sequence entire fetal genome by modifying prenatal testing method

Researchers develop way to sequence entire fetal genome by modifying prenatal testing method

For the first time, researchers have developed a way to sequence the entire genome of a fetus by modifying the prenatal testing method known as amniocentesis.

16 Mar 2018

Researchers identify novel gene involved in familial breast cancer

Researchers identify novel gene involved in familial breast cancer

An international research consortium led by Dr Jordi Surrallés, director of the Genetics Service at the Hospital de Sant Pau and professor of Genetics at the UAB, and by Dr Miquel Àngel Pujana, director of the ProCURE Research Programme of the Catalan Institute of Oncology, has identified a novel gene involved in this type of cancer, known as EDC4.

14 Mar 2018

Common genetic variation shown to increase Alzheimer’s risk

Common genetic variation shown to increase Alzheimer’s risk

A recent study has found that African Americans with a common genetic variation are at an increased risk for developing Alzheimer’s disease.

14 Mar 2018

Medical University of Vienna to partner with bio.logis GIM in pharmacogenetics

Medical University of Vienna to partner with bio.logis GIM in pharmacogenetics

Within the framework of U-PGx, an EU project for promoting the use of pharmacogenetic insights in healthcare, the Medical University of Vienna will implement the Genetic Information Management Suite developed by bio.logis Genetic Information Management GmbH.

14 Mar 2018

NIH-funded researchers use CRISPR to rapidly find new genetic suspects behind ALS, FTD

NIH-funded researchers use CRISPR to rapidly find new genetic suspects behind ALS, FTD

NIH-funded researchers at Stanford University used the gene editing tool CRISPR-Cas9 to rapidly identify genes in the human genome that might modify the severity of amyotrophic lateral sclerosis and frontotemporal dementia caused by mutations in a gene called C9orf72.

13 Mar 2018

Scientists link 110 genes to increased risk of breast cancer

Scientists link 110 genes to increased risk of breast cancer

Scientists have linked 110 genes to an increased risk of breast cancer in the most comprehensive study ever to unpick the genetics of the disease.

13 Mar 2018

Pittcon announces finalists in annual Pittcon Today Excellence Awards

Pittcon announces finalists in annual Pittcon Today Excellence Awards

Pittcon, the world’s leading conference and exposition for laboratory science, is pleased to announce the selection of ten finalists in the annual Pittcon Today Excellence Awards conducted by CE Communications, the official publishers of Pittcon Today and the Pittcon Buzz.

From Pittcon 12 Mar 2018

Researchers report genomic sequencing of 250,000 developmental cells

Researchers report genomic sequencing of 250,000 developmental cells

Researchers from the global Human Cell Atlas Consortium report that they have sequenced a quarter of a million separate cells that are of importance for early development of organs such as the liver, skin and kidneys. Sten Linnarsson at Karolinska Institutet is participating in the project.

9 Mar 2018

Modifying Oncolytic Adenoviruses to Target Pancreatic Cancer

Modifying Oncolytic Adenoviruses to Target Pancreatic Cancer

Pancreatic cancer is one of the less common but deadliest cancers. Modified oncolytic adenoviruses represent an alternative to chemotherapy and targeted therapies, which have a high mortality rate.

9 Mar 2018

Study sheds light on earliest stages in evolution of male-female sexes

Study sheds light on earliest stages in evolution of male-female sexes

A new study published in the journal Communications Biology has shed light on the earliest stages in the evolution of male-female differentiation and sex chromosomes--and found the genetic origins of the two sexes to be unexpectedly modest.

8 Mar 2018

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.